Benzyl N-[3-(difluoromethyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]-N-ethylcarbamate
C22H25F2N5O2 — CID 166688492
Data last refreshed: (MolForge compound catalog, from PubChem)
About Benzyl N-[3-(difluoromethyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]-N-ethylcarbamate
Benzyl N-[3-(difluoromethyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]-N-ethylcarbamate (PubChem CID 166688492) has the molecular formula C22H25F2N5O2 and a molecular weight of 429.47 g/mol. Its IUPAC name is benzyl N-[3-(difluoromethyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]-N-ethylcarbamate.
Molecular Properties
| Compound Name | Benzyl N-[3-(difluoromethyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]-N-ethylcarbamate |
|---|---|
| PubChem CID | 166688492 |
| Molecular Formula | C22H25F2N5O2 |
| Molecular Weight | 429.47 g/mol |
| Exact Mass | 429.20 |
| IUPAC Name | benzyl N-[3-(difluoromethyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]-N-ethylcarbamate |
| SMILES | CCN(C(=O)OCc1ccccc1)C1(C(F)F)CCCN(c2ncnc3[nH]ccc23)C1 |
| InChI | InChI=1S/C22H25F2N5O2/c1-2-29(21(30)31-13-16-7-4-3-5-8-16)22(20(23)24)10-6-12-28(14-22)19-17-9-11-25-18(17)26-15-27-19/h3-5,7-9,11,15,20H,2,6,10,12-14H2,1H3,(H,25,26,27) |
| InChIKey | LXHKCVAIPKNJAU-UHFFFAOYSA-N |
| XLogP | 4.22 |
| TPSA | 74.35 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 429.47 |
| LogP ≤ 5 | 4.22 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166688492 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.